Literature DB >> 6193248

The characterization of monoclonal antibodies to Newcastle disease virus.

P H Russell, P C Griffiths, K K Goswami, D J Alexander, M J Cannon, W C Russell.   

Abstract

Monoclonal antibodies to the haemagglutinin-neuraminidase (HN), fusion (F), polymerase and nucleocapsid polypeptides of Newcastle disease virus were prepared. Two epitopes were recognized on the HN polypeptide: one was associated with inhibition of haemagglutination and poor neutralization and the other with good neutralization and no inhibition of haemagglutination. The most effective neutralizing antibody was that produced against the F polypeptide. The poorer neutralization associated with the antibody against the HN epitope was augmented by antiglobulin or complement. The monoclonal antibodies that inhibited haemagglutination also inhibited neuraminidase activity when fetuin but not neuraminyl lactose was the substrate.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6193248     DOI: 10.1099/0022-1317-64-9-2069

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  16 in total

1.  Evaluation of mouse monoclonal antibodies raised against an isolate of the variant avian paramyxovirus type 1 responsible for the current panzootic in pigeons.

Authors:  M S Collins; D J Alexander; S Brockman; P A Kemp; R J Manvell
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

2.  Selection of unique antigenic variants of Newcastle disease virus with neutralizing monoclonal antibodies and anti-immunoglobulin.

Authors:  R M Iorio; M A Bratt
Journal:  Proc Natl Acad Sci U S A       Date:  1985-10       Impact factor: 11.205

3.  Antigenic relationships between avian paramyxoviruses. I. Quantitative characteristics based on hemagglutination and neuraminidase inhibition tests.

Authors:  M Lipkind; E Shihmanter
Journal:  Arch Virol       Date:  1986       Impact factor: 2.574

4.  Neutralizing activity of the antibodies against two kinds of envelope glycoproteins of Sendai virus.

Authors:  H Tozawa; H Komatsu; K Ohkata; T Nakajima; M Watanabe; Y Tanaka; M Arifuku
Journal:  Arch Virol       Date:  1986       Impact factor: 2.574

5.  The synergistic neutralization of Newcastle disease virus by two monoclonal antibodies to its haemagglutinin-neuraminidase protein.

Authors:  P H Russell
Journal:  Arch Virol       Date:  1986       Impact factor: 2.574

Review 6.  Monoclonal antibodies: implications for virology. Brief review.

Authors:  K C McCullough
Journal:  Arch Virol       Date:  1986       Impact factor: 2.574

7.  Characterization of reference strains of Newcastle disease virus (NDV) and NDV-like isolates by monoclonal antibodies to HN subunits.

Authors:  M Ishida; K Nerome; M Matsumoto; T Mikami; A Oya
Journal:  Arch Virol       Date:  1985       Impact factor: 2.574

8.  Characterization of paramyxoviruses isolated from penguins in Antarctica and sub-Antarctica during 1976-1979.

Authors:  D J Alexander; R J Manvell; M S Collins; S J Brockman; H A Westbury; I Morgan; F J Austin
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

9.  Characterization of French avian paramyxovirus type 1 (PMV 1) isolates with a Panel of monoclonal antibodies to the Ploufragan strain of Newcastle disease virus.

Authors:  V Jestin; M Cherbonnel; M Morin; M Guittet; G Bennejean
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

10.  Monoclonal antibodies to hemagglutinin-neuraminidase and fusion glycoproteins of Newcastle disease virus: relationship between glycosylation and reactivity.

Authors:  L Long; D Portetelle; J Ghysdael; M Gonze; A Burny; G Meulemans
Journal:  J Virol       Date:  1986-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.